Jose A. Gomez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jose A. Gomez has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Glenn Bauman
Department of Oncology, Division of Radiation Oncology, London Health Sciences Centre and Western University, London, ON, Canada
5 shared publications - Joseph L. Chin
Division of Urology, Department of Surgery, Western University, London, Canada
5 shared publications - Madeleine Moussa
Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
5 shared publications - Mena Gaed
Western University, Department of Pathology and Laboratory Medicine, 1151 Richmond St., London, ON N6A 3K7, Canada
5 shared publications - Stephen E. Pautler
Divisions of Urology and Surgical Oncology, Departments of Surgery and Oncology, Western University, London, Canada
5 shared publications - Ryan Alfano
Baines Imaging Research Laboratory, 790 Commissioners Rd E, London, ON N6A 5W9, Canada; Lawson Health Research Institute, 750 Base Line Rd E, London, ON N6C 2R5, Canada; Western University, Department of Medical Biophysics, 1151 Richmond St., London, ON N6A 3K7, Canada
4 shared publications
Latest Publications
- Open Access
- 20 March 2023
- Published by Elsevier in Urology Case Reports
- Vol. 48, 102388
Botryoid-type of embryonal rhabdomyosarcoma of the proximal and mid ureter in an adult woman
- 20 March 2023
- Published by Elsevier in Urology Case Reports
- Vol. 48, 102388
Open AccessBotryoid-type of embryonal rhabdomyosarcoma of the proximal and mid ureter in an adult woman
- 19 August 2022
- Published by Elsevier in European Journal of Radiology
- Vol. 156, 110494
Prostate cancer classification using radiomics and machine learning on mp-MRI validated using co-registered histology
- 19 August 2022
- Published by Elsevier in European Journal of Radiology
- Vol. 156, 110494
Prostate cancer classification using radiomics and machine learning on mp-MRI validated using co-registered histology
- Open Access
- 15 October 2021
- Published by Springer Nature in EJNMMI Research
- Vol. 11 (1) , 1-9
Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutes
Purpose: Localized prostate cancer (PCa) in patients is characterized by a dominant focus in the gland (dominant intraprostatic lesion, DIL). Accurate DIL identification may enable more accurate diagnosis and therapy through more precise targeting of biopsy, radiotherapy and focal ablative therapies. The goal of this study is to validate the performance of [18F]DCFPyL PET and CT perfusion (CTP) for detecting and localizing DIL against digital histopathological images. Methods: Multi-modality image sets: in vivo T2-weighted (T2w)-MRI, 22-min dynamic [18F]DCFPyL PET/CT, CTP, and 2-h post-injection PET/MR were acquired in patients prior to radical prostatectomy. The explanted gland with implanted fiducial markers was imaged with T2w-MRI. All images were co-registered to the pathologist-annotated digital images of whole-mount mid-gland histology sections using fiducial markers and anatomical landmarks. Regions of interest encompassing DIL and non-DIL tissue were drawn on the digital histopathological images and superimposed on PET and CTP parametric maps. Logistic regression with backward elimination of parameters was used to select the most sensitive parameter set to distinguish DIL from non-DIL voxels. Leave-one-patient-out cross-validation was performed to determine diagnostic performance. Results: [18F]DCFPyL PET and CTP parametric maps of 15 patients were analyzed. SUVLate and a model combining Ki and k4 of [18F]DCFPyL achieved the most accurate performance distinguishing DIL from non-DIL voxels. Both detection models achieved an AUC of 0.90 and an error rate of < 10%. Compared to digital histopathology, the detected DILs had a mean dice similarity coefficient of 0.8 for the Ki and k4 model and 0.7 for SUVLate. Conclusions: We have validated using co-registered digital histopathological images that parameters from kinetic analysis of 22-min dynamic [18F]DCFPyL PET can accurately localize DILs in PCa for targeting of biopsy, radiotherapy, and focal ablative therapies. Short-duration dynamic [18F]DCFPyL PET was not inferior to SUVLate in this diagnostic task. Clinical trial registration number: NCT04009174 (ClinicalTrials.gov).
- 15 October 2021
- Published by Springer Nature in EJNMMI Research
- Vol. 11 (1) , 1-9
Open AccessShort-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutes
Purpose: Localized prostate cancer (PCa) in patients is characterized by a dominant focus in the gland (dominant intraprostatic lesion, DIL). Accurate DIL identification may enable more accurate diagnosis and therapy through more precise targeting of biopsy, radiotherapy and focal ablative therapies. The goal of this study is to validate the performance of [18F]DCFPyL PET and CT perfusion (CTP) for detecting and localizing DIL against digital histopathological images. Methods: Multi-modality image sets: in vivo T2-weighted (T2w)-MRI, 22-min dynamic [18F]DCFPyL PET/CT, CTP, and 2-h post-injection PET/MR were acquired in patients prior to radical prostatectomy. The explanted gland with implanted fiducial markers was imaged with T2w-MRI. All images were co-registered to the pathologist-annotated digital images of whole-mount mid-gland histology sections using fiducial markers and anatomical landmarks. Regions of interest encompassing DIL and non-DIL tissue were drawn on the digital histopathological images and superimposed on PET and CTP parametric maps. Logistic regression with backward elimination of parameters was used to select the most sensitive parameter set to distinguish DIL from non-DIL voxels. Leave-one-patient-out cross-validation was performed to determine diagnostic performance. Results: [18F]DCFPyL PET and CTP parametric maps of 15 patients were analyzed. SUVLate and a model combining Ki and k4 of [18F]DCFPyL achieved the most accurate performance distinguishing DIL from non-DIL voxels. Both detection models achieved an AUC of 0.90 and an error rate of < 10%. Compared to digital histopathology, the detected DILs had a mean dice similarity coefficient of 0.8 for the Ki and k4 model and 0.7 for SUVLate. Conclusions: We have validated using co-registered digital histopathological images that parameters from kinetic analysis of 22-min dynamic [18F]DCFPyL PET can accurately localize DILs in PCa for targeting of biopsy, radiotherapy, and focal ablative therapies. Short-duration dynamic [18F]DCFPyL PET was not inferior to SUVLate in this diagnostic task. Clinical trial registration number: NCT04009174 (ClinicalTrials.gov).
- Open Access
- 30 July 2021
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 19, 102-107
Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation
- 30 July 2021
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 19, 102-107
Open AccessProstate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation
- 1 November 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 152, 34-41
Histologic validation of auto-contoured dominant intraprostatic lesions on [18F] DCFPyL PSMA-PET imaging
- 1 November 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 152, 34-41
Histologic validation of auto-contoured dominant intraprostatic lesions on [18F] DCFPyL PSMA-PET imaging
- 16 July 2020
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 7 (04) , 047501-23
Automatic cancer detection on digital histopathology images of mid-gland radical prostatectomy specimens
Purpose: Automatic cancer detection on radical prostatectomy (RP) sections facilitates graphical and quantitative surgical pathology reporting, which can potentially benefit postsurgery follow-up care and treatment planning. It can also support imaging validation studies using a histologic reference standard and pathology research studies. This problem is challenging due to the large sizes of digital histopathology whole-mount whole-slide images (WSIs) of RP sections and staining variability across different WSIs. Approach: We proposed a calibration-free adaptive thresholding algorithm, which compensates for staining variability and yields consistent tissue component maps (TCMs) of the nuclei, lumina, and other tissues. We used and compared three machine learning methods for classifying each cancer versus noncancer region of interest (ROI) throughout each WSI: (1) conventional machine learning methods and 14 texture features extracted from TCMs, (2) transfer learning with pretrained AlexNet fine-tuned by TCM ROIs, and (3) transfer learning with pretrained AlexNet fine-tuned with raw image ROIs. Results: The three methods yielded areas under the receiver operating characteristic curve of 0.96, 0.98, and 0.98, respectively, in leave-one-patient-out cross validation using 1.3 million ROIs from 286 mid-gland whole-mount WSIs from 68 patients. Conclusion: Transfer learning with the use of TCMs demonstrated state-of-the-art overall performance and is more stable with respect to sample size across different tissue types. For the tissue types involving Gleason 5 (most aggressive) cancer, it achieved the best performance compared to the other tested methods. This tool can be translated to clinical workflow to assist graphical and quantitative pathology reporting for surgical specimens upon further multicenter validation.
- 16 July 2020
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 7 (04) , 047501-23
Automatic cancer detection on digital histopathology images of mid-gland radical prostatectomy specimens
Purpose: Automatic cancer detection on radical prostatectomy (RP) sections facilitates graphical and quantitative surgical pathology reporting, which can potentially benefit postsurgery follow-up care and treatment planning. It can also support imaging validation studies using a histologic reference standard and pathology research studies. This problem is challenging due to the large sizes of digital histopathology whole-mount whole-slide images (WSIs) of RP sections and staining variability across different WSIs. Approach: We proposed a calibration-free adaptive thresholding algorithm, which compensates for staining variability and yields consistent tissue component maps (TCMs) of the nuclei, lumina, and other tissues. We used and compared three machine learning methods for classifying each cancer versus noncancer region of interest (ROI) throughout each WSI: (1) conventional machine learning methods and 14 texture features extracted from TCMs, (2) transfer learning with pretrained AlexNet fine-tuned by TCM ROIs, and (3) transfer learning with pretrained AlexNet fine-tuned with raw image ROIs. Results: The three methods yielded areas under the receiver operating characteristic curve of 0.96, 0.98, and 0.98, respectively, in leave-one-patient-out cross validation using 1.3 million ROIs from 286 mid-gland whole-mount WSIs from 68 patients. Conclusion: Transfer learning with the use of TCMs demonstrated state-of-the-art overall performance and is more stable with respect to sample size across different tissue types. For the tissue types involving Gleason 5 (most aggressive) cancer, it achieved the best performance compared to the other tested methods. This tool can be translated to clinical workflow to assist graphical and quantitative pathology reporting for surgical specimens upon further multicenter validation.